Pages that link to "Q48389633"

The following pages link to Adenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation (Q48389633):

Displaying 25 items.

• Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. (Q33709251) (← links)
• Sleep deprivation therapy in depressive illness and Parkinson's disease (Q33745822) (← links)
• D1 dopamine receptors (Q34349190) (← links)
• Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release (Q34792220) (← links)
• Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. (Q35489240) (← links)
• A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists. (Q38169996) (← links)
• Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease (Q41622546) (← links)
• Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia (Q41624006) (← links)
• Potential role of adenosine antagonist therapy in pathological tremor disorders (Q41639796) (← links)
• Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes (Q41903478) (← links)
• Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats (Q42548750) (← links)
• SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats (Q43635686) (← links)
• Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation. (Q44050773) (← links)
• Selective A2A, but not A1 adenosine antagonists enhance the anticataleptic action of trihexyphenidyl in rats (Q44506257) (← links)
• Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease (Q44865042) (← links)
• Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas (Q48684664) (← links)
• Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen (Q48730493) (← links)
• Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats (Q48795844) (← links)
• Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: evidence for an A2a/D2 receptor interaction in globus pallidus (Q49133941) (← links)
• The effect of theophylline on parkinsonian symptoms. (Q54028913) (← links)
• Modulation by adenosine A2A receptors of dopamine-mediated motor behavior as a basis for antiparkinson?s disease drugs (Q60643597) (← links)
• Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys (Q71764785) (← links)
• Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats (Q74578998) (← links)
• Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia (Q74746934) (← links)
• Dopamine receptor pharmacology (Q82029300) (← links)